$9.38
3.88% yesterday
Nasdaq, Sep 29, 10:00 pm CET
ISIN
US78349D1072
Symbol
RXST

RxSight Inc Stock price

$9.03
+0.53 6.24% 1M
-15.34 62.95% 6M
-25.35 73.73% YTD
-39.87 81.53% 1Y
-2.16 19.30% 3Y
-6.97 43.56% 5Y
-6.97 43.56% 10Y
-6.97 43.56% 20Y
Nasdaq, Closing price Fri, Sep 26 2025
-0.03 0.28%

Key metrics

Basic
Market capitalization
$369.5m
Enterprise Value
$142.1m
Net debt
positive
Cash
$227.5m
Shares outstanding
40.9m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
2.5 | 2.9
EV/Sales
1.0 | 1.1
EV/FCF
negative
P/B
1.3
Financial Health
Equity Ratio
88.3%
Return on Equity
-9.8%
ROCE
-14.7%
ROIC
-
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$147.1m | $128.0m
EBITDA
$-39.3m | $-47.5m
EBIT
$-42.5m | $-60.1m
Net Income
$-32.3m | $-51.3m
Free Cash Flow
$-20.9m
Growth (TTM | estimate)
Revenue
27.7% | -8.5%
EBITDA
7.0% | -28.9%
EBIT
-0.4% | -63.1%
Net Income
12.3% | -86.9%
Free Cash Flow
40.9%
Margin (TTM | estimate)
Gross
73.1%
EBITDA
-26.7% | -37.1%
EBIT
-28.9%
Net
-21.9% | -40.1%
Free Cash Flow
-14.2%
More
EPS
$-0.8
FCF per Share
$-0.5
Short interest
12.3%
Employees
498
Rev per Employee
$280.0k
Show more

Is RxSight Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,009 stocks worldwide.

RxSight Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

16 Analysts have issued a RxSight Inc forecast:

1x Buy
6%
10x Hold
63%
5x Sell
31%

Analyst Opinions

16 Analysts have issued a RxSight Inc forecast:

Buy
6%
Hold
63%
Sell
31%

Financial data from RxSight Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
147 147
28% 28%
100%
- Direct Costs 40 40
2% 2%
27%
108 108
41% 41%
73%
- Selling and Administrative Expenses 111 111
27% 27%
76%
- Research and Development Expense 39 39
26% 26%
26%
-39 -39
7% 7%
-27%
- Depreciation and Amortization 3.23 3.23
2,836% 2,836%
2%
EBIT (Operating Income) EBIT -43 -43
0% 0%
-29%
Net Profit -32 -32
12% 12%
-22%

In millions USD.

Don't miss a Thing! We will send you all news about RxSight Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

RxSight Inc Stock News

Neutral
Business Wire
7 days ago
NEW YORK--(BUSINESS WIRE)---- $RXST #ClassAction--Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against RxSight, Inc. (“RxSight” or the “Company”) (NASDAQ: RXST) and reminds investors of the September 22, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. Faruqi & Faruqi...
Neutral
Seeking Alpha
7 days ago
RxSight may be outlining a 'ski-jump' technical pattern, suggesting the potential for a sharp short-term rebound. RXST holds $227 million in cash against $31 million in total liabilities, limiting downside risk with $379 million in equity market cap. The company's cash runway is estimated at 5-10 years, with manageable annual cash burn of $20-30 million.
Neutral
PRNewsWire
8 days ago
LOS ANGELES , Sept. 22, 2025 /PRNewswire/ -- The DJS Law Group announces that it is investigating claims on behalf of investors of RxSight, Inc. ("RxSight" or "the Company") (NASDAQ: RXST) for violations of the securities laws.
More RxSight Inc News

Company Profile

RxSight, Inc. engages in the research, development, manufacture, and sale of light adjustable lenses and related capital equipment. It also commercializes adjustable intraocular lens (IOL) that is customized after cataract surgery The company was founded by Robert Grubbs and Daniel Schwartz on March 5, 1997 and is headquartered in Aliso Viejo, CA.

Head office United States
CEO Ronald Kurtz
Employees 498
Founded 1997
Website www.rxsight.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today